EP300 and acute myeloid leukemia: Some related compounds reported by us as epi-MLs exerted biochemical inhibition of a number of epigenetic targets (PRMTs, KMTs, p300, SIRT1/2), joined to potent induction of apoptosis and/or cytodifferentiation in U937 AML cells [13].